London Co. of Virginia Sells 14,832 Shares of Ingevity Corporation $NGVT

London Co. of Virginia trimmed its position in Ingevity Corporation (NYSE:NGVTFree Report) by 3.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 469,478 shares of the company’s stock after selling 14,832 shares during the period. London Co. of Virginia’s holdings in Ingevity were worth $25,911,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Oakworth Capital Inc. purchased a new stake in Ingevity during the third quarter valued at approximately $28,000. Geneos Wealth Management Inc. raised its position in Ingevity by 85.8% in the second quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock worth $36,000 after acquiring an additional 387 shares during the period. Headlands Technologies LLC purchased a new position in shares of Ingevity during the 2nd quarter worth $46,000. Elevation Point Wealth Partners LLC bought a new stake in shares of Ingevity during the 2nd quarter valued at $60,000. Finally, EverSource Wealth Advisors LLC grew its position in shares of Ingevity by 51.6% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,616 shares of the company’s stock valued at $70,000 after acquiring an additional 550 shares during the period. 91.59% of the stock is currently owned by institutional investors.

Ingevity Stock Up 1.5%

Shares of NGVT stock opened at $65.57 on Tuesday. The company has a debt-to-equity ratio of 39.10, a current ratio of 1.33 and a quick ratio of 0.79. Ingevity Corporation has a one year low of $28.49 and a one year high of $77.46. The company’s fifty day moving average price is $68.76 and its 200-day moving average price is $60.02. The company has a market capitalization of $2.31 billion, a price-to-earnings ratio of -14.10 and a beta of 1.31.

Ingevity (NYSE:NGVTGet Free Report) last issued its earnings results on Wednesday, February 25th. The company reported $0.58 earnings per share for the quarter, missing the consensus estimate of $0.74 by ($0.16). Ingevity had a positive return on equity of 126.25% and a negative net margin of 13.51%.The firm had revenue of $255.10 million during the quarter, compared to the consensus estimate of $257.27 million. During the same period in the prior year, the company posted $0.95 EPS. The company’s quarterly revenue was down 3.2% on a year-over-year basis. Ingevity has set its FY 2026 guidance at 4.800-5.20 EPS. Sell-side analysts expect that Ingevity Corporation will post 4.45 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Ingevity in a report on Thursday, January 22nd. BMO Capital Markets reissued an “outperform” rating and set a $83.00 price target on shares of Ingevity in a report on Monday, March 2nd. Wall Street Zen cut Ingevity from a “strong-buy” rating to a “buy” rating in a research report on Monday, March 9th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $82.00 price objective on shares of Ingevity in a research note on Thursday, February 26th. Finally, Zacks Research raised Ingevity to a “hold” rating in a research report on Tuesday, December 16th. Two analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Ingevity has a consensus rating of “Hold” and an average price target of $80.00.

Read Our Latest Report on NGVT

Ingevity Company Profile

(Free Report)

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.

Recommended Stories

Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corporation (NYSE:NGVTFree Report).

Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.